Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TroVax + IL-2 in Advanced Renal Carcinoma
NCT00325507Phase 2Completed
- Sponsor
- Oxford BioMedica
- Start
- Nov 2005
- Primary completion
- Jul 2008
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-5T4 in renal cell carcinoma (RCC), sponsored by Oxford BioMedica. Started Nov 2005; status: completed.
02
Drugs
MVA-5T4
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00325507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325507.